Works matching IS 11727047 AND DT 2020 AND VI 34 AND IP 8
Results: 7
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 801, doi. 10.1007/s40263-020-00747-z
- By:
- Publication type:
- Article
Methadone for Pain Management: A Pharmacotherapeutic Review.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 827, doi. 10.1007/s40263-020-00743-3
- By:
- Publication type:
- Article
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 795, doi. 10.1007/s40263-020-00741-5
- By:
- Publication type:
- Article
Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 785, doi. 10.1007/s40263-020-00740-6
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 853, doi. 10.1007/s40263-020-00738-0
- By:
- Publication type:
- Article
Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 841, doi. 10.1007/s40263-020-00735-3
- By:
- Publication type:
- Article